question: Compared to chemoimmunotherapy without bevacizumab (PCR) what was the result of chemoimmunotherapy with bevacizumab (PCR-B) on PFS and TFS by IGHV mutational status?
context: A significant post-treatment increase in VEGF levels was observed in the PCR-B arm (29.77 to 57.05 pg/mL)